Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Hande

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in ratsP M Ormond, M A Basinger, M M Jones, et al.
Biochemical Pharmacology|March 16, 2010
Cytidine and deoxycytidylate deaminase inhibition by uridine analogsJ C Drake, K R Hande, R W Fuller, et al.
American Journal of Clinical Oncology|August 1, 1989
Chemotherapy of advanced non-small-cell lung cancer: a randomized trial of three cis-platin-based chemotherapy regimensJ D Hainsworth, D H Johnson, K R Hande, et al.
Infection and Immunity|May 1, 1971
Comparative production of interferon by human fetal, neonatal, and maternal cellsW A Carter, K R Hande, B Essien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trialD H Johnson, F A Greco, J Strupp, et al.
Bibliotheca Haematologica|October 1, 1975
Biochemical pharmacology of cytidine analog metabolism in human leukemic cellsR G Stoller, C N Coleman, P Chang, et al.
Seminars in Oncology|August 1, 1997
Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: a Vanderbilt Cancer Center phase II trialB Nicholson, D Paul, Y Shyr, et al.
Cancer|February 15, 2001
A randomized Phase II trial in patients with carcinoma of an unknown primary siteJ E Dowell, A M Garrett, Y Shyr, et al.
Oncology|January 1, 1992
Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trialD H Johnson, J D Hainsworth, R DeVore, et al.
Cancer|June 1, 1994
Prolonged administration of low dose infusional etoposide in patients with advanced malignancies. A phase I/II studyD S Thompson, J D Hainsworth, K R Hande, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in ratsP M Ormond, M A Basinger, M M Jones, et al.
Biochemical Pharmacology|March 16, 2010
Cytidine and deoxycytidylate deaminase inhibition by uridine analogsJ C Drake, K R Hande, R W Fuller, et al.
American Journal of Clinical Oncology|August 1, 1989
Chemotherapy of advanced non-small-cell lung cancer: a randomized trial of three cis-platin-based chemotherapy regimensJ D Hainsworth, D H Johnson, K R Hande, et al.
Infection and Immunity|May 1, 1971
Comparative production of interferon by human fetal, neonatal, and maternal cellsW A Carter, K R Hande, B Essien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trialD H Johnson, F A Greco, J Strupp, et al.
Bibliotheca Haematologica|October 1, 1975
Biochemical pharmacology of cytidine analog metabolism in human leukemic cellsR G Stoller, C N Coleman, P Chang, et al.
Seminars in Oncology|August 1, 1997
Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: a Vanderbilt Cancer Center phase II trialB Nicholson, D Paul, Y Shyr, et al.
Cancer|February 15, 2001
A randomized Phase II trial in patients with carcinoma of an unknown primary siteJ E Dowell, A M Garrett, Y Shyr, et al.
Oncology|January 1, 1992
Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trialD H Johnson, J D Hainsworth, R DeVore, et al.
Cancer|June 1, 1994
Prolonged administration of low dose infusional etoposide in patients with advanced malignancies. A phase I/II studyD S Thompson, J D Hainsworth, K R Hande, et al.
Pageof 11